The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.2M data for 1.4M Compounds and 11.5K Targets. Of those, 1.6M data for 765K Compounds and 4.8K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

To help with training and testing AI and other models, BindingDB downloads and search results now provide the publication date and BindingDB curation date of each measurement.

9 articles for R Guan


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Cmpds
Data
Article Title
Organization
4
Tight binding enantiomers of pre-clinical drug candidates.EBI
Victoria University of Wellington
1
Advances in the studies of roles of Rho/Rho-kinase in diseases and the development of its inhibitors.EBI
Sun Yat-Sen University
38
1,4-Dihydroindeno[1,2-c]pyrazoles as potent checkpoint kinase 1 inhibitors: extended exploration on phenyl ring substitutions and preliminary ADME/PK studies.EBI
Abbott Laboratories
300
Therapeutic thiophene-, furan-, and pyridine-fused azolopyrimidin-5-(6h)-onesBDB
Dart Neuroscience (Cayman)
6
Organic compoundsBDB
Intra-Cellular Therapies
84
Fused pyrimidine compound or salt thereofBDB
Taiho Pharmaceutical
31
5-Amidinobenzo[b]thiophenes as dual inhibitors of factors IXa and Xa.BDB
Bristol Myers Squibb
26
2-Aminoquinazoline inhibitors of cyclin-dependent kinases.BDB
Naeja Pharmaceutical
18
The discovery of N-(1,3-thiazol-2-yl)pyridin-2-amines as potent inhibitors of KDR kinase.BDB
Merck Research Laboratories